EPS for Micron Technology, Inc. (MU) Expected At $2.69; Corcept Therapeutics (CORT) Covered By 4 Bullish Analysts Last Week

February 21, 2018 - By Darrin Black

Analysts expect Micron Technology, Inc. (NASDAQ:MU) to report $2.69 EPS on March, 22 after the close.They anticipate $1.92 EPS change or 249.35% from last quarter’s $0.77 EPS. MU’s profit would be $3.11 billion giving it 4.21 P/E if the $2.69 EPS is correct. After having $2.41 EPS previously, Micron Technology, Inc.’s analysts see 11.62% EPS growth. The stock increased 0.87% or $0.39 during the last trading session, reaching $45.29. About 13.58 million shares traded. Micron Technology, Inc. (NASDAQ:MU) has risen 176.27% since February 21, 2017 and is uptrending. It has outperformed by 159.57% the S&P500.

Among 4 analysts covering Corcept Therapeutics (NASDAQ:CORT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Corcept Therapeutics had 7 analyst reports since February 2, 2017 according to SRatingsIntel. As per Thursday, February 2, the company rating was initiated by Ladenburg Thalmann. The firm earned “Buy” rating on Wednesday, October 11 by Piper Jaffray. As per Thursday, August 24, the company rating was maintained by Piper Jaffray. On Friday, November 3 the stock rating was maintained by Stifel Nicolaus with “Buy”. The stock of Corcept Therapeutics Incorporated (NASDAQ:CORT) earned “Buy” rating by Piper Jaffray on Friday, September 8. See Corcept Therapeutics Incorporated (NASDAQ:CORT) latest ratings:

03/11/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $25.0 Maintain
11/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $24.0 Maintain
08/09/2017 Broker: Piper Jaffray Rating: Buy New Target: $24.0 Maintain
31/08/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $20 Initiates Coverage On
24/08/2017 Broker: Piper Jaffray Rating: Buy New Target: $18.0 Maintain

The stock increased 3.78% or $0.58 during the last trading session, reaching $15.93. About 615,606 shares traded. Corcept Therapeutics Incorporated (NASDAQ:CORT) has risen 124.81% since February 21, 2017 and is uptrending. It has outperformed by 108.11% the S&P500.

Investors sentiment decreased to 1.96 in 2017 Q3. Its down 0.47, from 2.43 in 2017Q2. It fall, as 13 investors sold Corcept Therapeutics Incorporated shares while 39 reduced holdings. 47 funds opened positions while 55 raised stakes. 71.96 million shares or 6.38% more from 67.64 million shares in 2017Q2 were reported. Dupont Mgmt has 0.05% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT). Menta Cap Limited stated it has 67,993 shares or 0.19% of all its holdings. Acadian Asset Ltd Liability Co has invested 0.2% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Sheets Smith Wealth Mngmt invested in 23,727 shares. California Employees Retirement Systems has invested 0% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Virginia Retirement Systems Et Al owns 0.03% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 108,500 shares. Lord Abbett And Company Limited Company owns 203,332 shares or 0.01% of their US portfolio. Moreover, Tanaka Mgmt has 6.02% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT). Jacobs Levy Equity Mgmt Inc accumulated 19,810 shares or 0.01% of the stock. Moreover, National Bank Of Montreal Can has 0% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 27,161 shares. Lpl Limited Co accumulated 51,258 shares. Asset Mngmt owns 0.04% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 12,376 shares. Millennium Ltd Limited Liability Company reported 0.02% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT). Cornerstone Mngmt Ltd accumulated 0.02% or 105,000 shares. Credit Suisse Ag holds 114,440 shares.

Since December 8, 2017, it had 0 insider purchases, and 3 sales for $415,899 activity. FISHMAN ROBERT S also sold $133,776 worth of Corcept Therapeutics Incorporated (NASDAQ:CORT) shares.

Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company has market cap of $1.82 billion. It offers Korlym tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It has a 54.93 P/E ratio. The firm is also developing Korlym in combination with eribulin, which is in Phase I/II clinical trial to treat patients with metastatic triple-negative breast cancer; Korlym in combination with drug Abraxane that is in Phase II clinical trial to treat patients with triple-negative breast cancer; and Korlym combined with the androgen deprivation agent enzalutamide, which is in Phase II clinical trial to treat patients with metastatic castration-resistant prostate cancer.

Among 42 analysts covering Micron Technology Inc. (NASDAQ:MU), 36 have Buy rating, 0 Sell and 6 Hold. Therefore 86% are positive. Micron Technology Inc. had 214 analyst reports since July 29, 2015 according to SRatingsIntel. On Monday, February 5 the stock rating was upgraded by KeyBanc Capital Markets to “Buy”. The firm has “Neutral” rating by Wedbush given on Friday, September 25. KeyBanc Capital Markets maintained the shares of MU in report on Friday, June 30 with “Hold” rating. On Friday, October 9 the stock rating was maintained by Mizuho with “Neutral”. The stock of Micron Technology, Inc. (NASDAQ:MU) has “Buy” rating given on Thursday, December 24 by Argus Research. On Wednesday, August 23 the stock rating was maintained by Robert W. Baird with “Buy”. The rating was maintained by Loop Capital on Friday, October 13 with “Buy”. As per Wednesday, May 24, the company rating was downgraded by Standpoint Research. The firm has “Hold” rating by BMO Capital Markets given on Monday, October 9. Nomura upgraded Micron Technology, Inc. (NASDAQ:MU) on Thursday, June 23 to “Buy” rating.

Since September 1, 2017, it had 0 insider purchases, and 15 insider sales for $14.83 million activity. $129,520 worth of Micron Technology, Inc. (NASDAQ:MU) was sold by BAILEY ROBERT L on Thursday, February 1. Shares for $3.09 million were sold by Poppen Joel L. Another trade for 16,950 shares valued at $701,730 was sold by Deboer Scott J. Mondry Lawrence N also sold $2.17M worth of Micron Technology, Inc. (NASDAQ:MU) shares. $4.53M worth of stock was sold by Thorsen Steven L. JR on Friday, September 29. $53,487 worth of stock was sold by ARNZEN APRIL S on Thursday, February 15.

Investors sentiment increased to 1.37 in 2017 Q3. Its up 0.29, from 1.08 in 2017Q2. It increased, as 52 investors sold Micron Technology, Inc. shares while 205 reduced holdings. 114 funds opened positions while 237 raised stakes. 886.67 million shares or 6.47% more from 832.79 million shares in 2017Q2 were reported. Moreover, Acadian Asset Management Ltd Liability Co has 0% invested in Micron Technology, Inc. (NASDAQ:MU) for 4,496 shares. Friess Associates Limited Liability Corp, Wyoming-based fund reported 470,790 shares. Williams Jones And Associate Ltd Company reported 397,075 shares or 0.38% of all its holdings. Boston Advisors Lc, a Massachusetts-based fund reported 759,695 shares. Martingale Asset Mgmt Lp accumulated 26,143 shares. Systematic Fincl Management Ltd Partnership has invested 0.58% in Micron Technology, Inc. (NASDAQ:MU). Lombard Odier Asset Mngmt (Switzerland) Sa stated it has 47,022 shares. 2.52 million are held by Dnb Asset As. Amica Pension Fund Board Of Trustees invested in 0.18% or 37,209 shares. 86,211 are held by Vident Investment Advisory Ltd Company. Caxton Associates Lp invested in 0.53% or 379,200 shares. Virtus Invest Advisers invested in 25,658 shares or 0.11% of the stock. Da Davidson & has invested 0.02% in Micron Technology, Inc. (NASDAQ:MU). Westfield Management Co L P holds 0.55% of its portfolio in Micron Technology, Inc. (NASDAQ:MU) for 1.83M shares. New York-based Virtu Fincl Ltd Limited Liability Company has invested 0% in Micron Technology, Inc. (NASDAQ:MU).

Micron Technology, Inc. provides semiconductor systems worldwide. The company has market cap of $52.37 billion. The firm operates through four divisions: Compute and Networking Business Unit, Storage Business Unit, Mobile Business Unit, and Embedded Business Unit. It has a 7.08 P/E ratio. It offers DDR3 and DDR4 DRAM products for computers, servers, networking devices, communications equipment, consumer electronics, automotive, and industrial applications; mobile low-power DRAM products for smartphones, tablets, automotive, laptop computers, and other mobile consumer device applications; DDR2 and DDR DRAM, GDDR5 and GDDR5X DRAM, SDRAM, and RLDRAM products for networking devices, servers, consumer electronics, communications equipment, computer peripherals, automotive and industrial applications, and computer memory upgrades; and hybrid memory cube semiconductor memory devices for use in networking and computing applications.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: